Michael Mor

6PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersHaematologyNanomaterialsBiologically active moleculesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 25, 2026
Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.

Aakanksha Harit, Michael Mor, Ron Yefet

|Jun 30, 2025
The GATE glycoprotein complex enhances human cytomegalovirus entry in endothelial cells.

Michael J Norris, Lauren A Henderson, Mohammed N A Siddiquey

|Aug 08, 2024
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Rita C Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi

|Aug 05, 2022
Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies.

Ruofan Li, Michael Mor, Bingting Ma

|Feb 11, 2021
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.

Michael Mor, Michal Werbner, Joel Alter

Pageof 1